These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 15176948)

  • 41. Development of a vaccine against Schistosoma japonicum in China: a review.
    Wu ZD; Lü ZY; Yu XB
    Acta Trop; 2005; 96(2-3):106-16. PubMed ID: 16168945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Challenge of developing anti-parasite vaccines in the tropics].
    Rogier C
    Med Trop (Mars); 2007 Aug; 67(4):328-34. PubMed ID: 17926789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Saposin-like proteins are expressed in the gastrodermis of Schistosoma mansoni and are immunogenic in natural infections.
    Don TA; Bethony JM; Loukas A
    Int J Infect Dis; 2008 Nov; 12(6):e39-47. PubMed ID: 18571965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current status and future prospects for a vaccine against American trypanosomiasis.
    Garg N; Bhatia V
    Expert Rev Vaccines; 2005 Dec; 4(6):867-80. PubMed ID: 16372882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of immune evasion in schistosomiasis.
    Pearce EJ; Sher A
    Contrib Microbiol Immunol; 1987; 8():219-32. PubMed ID: 3304833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibody Signatures Reflect Different Disease Pathologies in Patients With Schistosomiasis Due to Schistosoma japonicum.
    Driguez P; Li Y; Gaze S; Pearson MS; Nakajima R; Trieu A; Doolan DL; Felgner PL; Hou X; Cardoso FC; Jasinskas A; Gobert GN; Loukas A; McManus DP
    J Infect Dis; 2016 Jan; 213(1):122-30. PubMed ID: 26150545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Schistosomiasis vaccine development--the current picture.
    Waine GJ; McManus DP
    Bioessays; 1997 May; 19(5):435-43. PubMed ID: 9174407
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune responses against Schistosoma japonicum after vaccinating mice with a multivalent DNA vaccine encoding integrated membrane protein Sj23 and cytokine interleukin-12.
    Gan Y; Shi YE; Bu LY; Zhu XH; Ning CX; Zhu HG
    Chin Med J (Engl); 2004 Dec; 117(12):1842-6. PubMed ID: 15603716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis.
    Tran MH; Pearson MS; Bethony JM; Smyth DJ; Jones MK; Duke M; Don TA; McManus DP; Correa-Oliveira R; Loukas A
    Nat Med; 2006 Jul; 12(7):835-40. PubMed ID: 16783371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral administration of a live Aro attenuated Salmonella vaccine strain expressing 14-kDa Schistosoma mansoni fatty acid-binding protein induced partial protection against experimental schistosomiasis.
    Pacheco LG; Zucconi E; Mati VL; Garcia RM; Miyoshi A; Oliveira SC; de Melo AL; Azevedo V
    Acta Trop; 2005 Aug; 95(2):132-42. PubMed ID: 15993833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The protective effect of a Schistosoma japonicum Chinese strain 23 kDa plasmid DNA vaccine in pigs is enhanced with IL-12.
    Zhu Y; Ren J; Da'dara A; Harn D; Xu M; Si J; Yu C; Liang Y; Ye P; Yin X; He W; Xu Y; Cao G; Hua W
    Vaccine; 2004 Nov; 23(1):78-83. PubMed ID: 15519710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thomsen-Friedenreich oncofetal antigen in Schistosoma mansoni : localization and immunogenicity in experimental mouse infection.
    Thors C; Jansson B; Helin H; Linder E
    Parasitology; 2006 Jan; 132(Pt 1):73-81. PubMed ID: 16393356
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advancing a vaccine to prevent human schistosomiasis.
    Merrifield M; Hotez PJ; Beaumier CM; Gillespie P; Strych U; Hayward T; Bottazzi ME
    Vaccine; 2016 Jun; 34(26):2988-2991. PubMed ID: 27036511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell-mediated immunity to schistosomes. Evaluation of mechanisms operating against lung-stage parasites which might be exploited in a vaccine.
    Pemberton RM; Malaquias LC; Falcao PL; Silveira AM; Rabello AL; Katz N; Amorim M; Mountford AP; Coffman RL; Correa-Oliveira R
    Trop Geogr Med; 1994; 46(4 Spec No):247-54. PubMed ID: 7825229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Schistosome vaccines: a critical appraisal.
    Wilson RA; Coulson PS
    Mem Inst Oswaldo Cruz; 2006 Sep; 101 Suppl 1():13-20. PubMed ID: 17308743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cluster analysis of schistosome-specific antibody responses partitions the population into distinct epidemiological groups.
    Mutapi F; Mduluza T; Roddam AW
    Immunol Lett; 2005 Jan; 96(2):231-40. PubMed ID: 15585328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Schistosomiasis vaccines.
    Siddiqui AA; Siddiqui BA; Ganley-Leal L
    Hum Vaccin; 2011 Nov; 7(11):1192-7. PubMed ID: 22048120
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Th2 response polarization during infection with the helminth parasite Schistosoma mansoni.
    Pearce EJ; M Kane C; Sun J; J Taylor J; McKee AS; Cervi L
    Immunol Rev; 2004 Oct; 201():117-26. PubMed ID: 15361236
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Still hope for schistosomiasis vaccine.
    Ricciardi A; Ndao M
    Hum Vaccin Immunother; 2015; 11(10):2504-8. PubMed ID: 26176659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.